Brief: Fujian Haixi Pharmaceuticals Discloses Final Offer Price HK$86.40 Per H Share Under Global Offering
17/10/2025 16:04
Oct 17 (Reuters) - Fujian Haixi Pharmaceuticals Co Ltd 2637.HK: FINAL OFFER PRICE HK$86.40 PER H SHARE UNDER GLOBAL OFFERING Further company coverage: 2637.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fujian Haixi Pharmaceuticals
See all newsBrief: Fujian Haixi Pharmaceuticals Says HX9428 Granted Fast Track Designation By U.S. FDA
Fujian Haixi jumps on initial approval of HX9428 for macular degeneration treatment
Brief: Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428
Brief: Fujian Haixi Pharmaceuticals Elects Chen Tingze As Executive Director
Brief: Fujian Haixi Pharmaceuticals Nominates Chen Tingze As Candidate For Executive Director